Cancer treatment at Asan Medical Centre
Asan is a leader in cancer treatment in Korea due to its comprehensive and multidisciplinary approach. Specialists from various fields including diagnostic, surgical, medical and radiation oncology work together to develop personalised treatment plans for each patient. Asan Cancer Institute has 17 specialised centres, providing individualised treatment for each type of cancer. The clinic also performs the highest number of tumour surgeries in Korea and has the highest survival rates among patients.
Each department of the Cancer Institute offers specialised treatment for specific types of cancer. The main areas of work of the institute are:
Over 1,1 million patients have been treated there. More than 1 million outpatient visits were registered, and the number of inpatient days is over 83,662. Over 36,000 new patients are referred to specialists per year, about 23,000 surgical operations are performed and 7,000 consultations within multidisciplinary clinics. The department carried out 234,606 courses of chemotherapy and 112,221 sessions of radiotherapy. More than 5,000 patients underwent genetic tests and 594 clinical trials were organised.
The Cancer Institute of Asan Hospital has achieved significant results in cancer treatment. The centre has performed the highest number of gastric cancer surgeries and laparoscopic cervical surgeries in the world. The hospital also leads Korea in the number of annual cancer surgeries, particularly for liver, pancreatic, biliary, colorectal and breast cancer. Korea’s first multidisciplinary cancer centre was established here in 2006, followed by a centre for personalised medicine in 2012. In 2020, a precision medicine centre was opened, greatly enhancing precision diagnosis and treatment capabilities.
The institute’s equipment includes robotic surgical systems that enable complex surgeries to be performed. The clinic has performed more than 500 robotic oesophageal surgeries, the highest number in Asia. The clinic also has state-of-the-art systems for rapid diagnosis, chemotherapy infusion centres and patient data management platforms.